| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/21/2005 | CA2542034A1 Thiadiazoline derivatives |
| 04/21/2005 | CA2540051A1 Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase the life expectancy of human beings |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/20/2005 | EP1524263A1 prodrugs containing cycloalkene derivatives |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523980A2 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 04/20/2005 | EP1523571A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523489A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/20/2005 | EP1523486A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 04/20/2005 | EP1523484A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1523470A1 Novel compounds as histone deacetylase inhibitors |
| 04/20/2005 | EP1523469A1 Cinnamide derivatives |
| 04/20/2005 | EP1523326A2 Insulin-associated peptides with effects on cerebral health |
| 04/20/2005 | EP1523321A1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 04/20/2005 | EP1523318A2 Treatment of human multiple myeloma by curcumin |
| 04/20/2005 | EP1523316A2 Combination comprising an hmg-coa reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 04/20/2005 | EP1523312A1 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 04/20/2005 | EP1523311A1 Calcium lactate and whey permeate for lowering the triglyceride level |
| 04/20/2005 | EP1523310A2 Method to inhibit ischemia and reperfusion injury |
| 04/20/2005 | EP1458355A4 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 04/20/2005 | EP1443921B1 Production of pure stereoisomers of tricyclo-[5.2.1.0(2.6)]-dec-9-yl-xanthate esters and their use as medicaments |
| 04/20/2005 | EP1383494A4 Compositions and methods for the prevention and treatment of human prostate cancer |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1349843B1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 04/20/2005 | EP1318829B1 Angiogenic tri- or tetrapeptides derived from AcSDKP |
| 04/20/2005 | EP1315807B1 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides |
| 04/20/2005 | EP1307446B1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 04/20/2005 | EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 04/20/2005 | EP1283839B1 Adenosine a2a receptor antagonists |
| 04/20/2005 | EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1226110B1 Bicyclic amino acids as pharmaceutical agents |
| 04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
| 04/20/2005 | EP1178810B1 Use of bisphosphonic acids for treating angiogenesis |
| 04/20/2005 | EP1177185B1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | EP1144395B1 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | EP1143977B1 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | EP1141326B1 Human akt-3 |
| 04/20/2005 | EP1140904B1 Farnesyl protein transferase inhibitors |
| 04/20/2005 | EP1076651B1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 04/20/2005 | EP1001685B1 Nutritional compositions containing methionine |
| 04/20/2005 | EP0831886B1 Thrombopoietin compositions |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/20/2005 | EP0721455B9 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 04/20/2005 | CN1608135A Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608064A Novel compounds |
| 04/20/2005 | CN1608063A Indolinone derivatives |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1608060A Diaryl 1, 2, 4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608059A Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608056A Carboxylic acid derivative compounds and agents comprising the compounds as active ingredient |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1608053A Heterocyclic derivatives of glycinamide and its pharmaceutical uses |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607957A Modulation of excitable tissue function by peripherally administered erythropoietin |
| 04/20/2005 | CN1607954A Pregnane steroids for use in the treatment of cns dysfunction |
| 04/20/2005 | CN1607952A Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 04/20/2005 | CN1607951A Quinoline derivatives as neuropeptide y antagonists |
| 04/20/2005 | CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 04/20/2005 | CN1607938A Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 04/20/2005 | CN1606994A Nanometer compound Chinese medicinal formulation for treating brain atrophy and its preparing method |
| 04/20/2005 | CN1606988A Fire purging medicine and its preparation |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197960C Immortalized human kerationocyte cell line |
| 04/20/2005 | CN1197874C Modification and preparation of human interleukin 11 |
| 04/20/2005 | CN1197871C 5'-deoxy-cytidine derivatives |
| 04/20/2005 | CN1197867C Application of cinidium general coumarin as psoriasis treating medicine |
| 04/20/2005 | CN1197863C Novel octahydro-2H-pyridino-[1, 2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 04/20/2005 | CN1197860C FAB I inhibitors |
| 04/20/2005 | CN1197854C Lactonization processing method in preparing Tating compounds |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197622C Emulsion-type lubricant for medical appliance and its application in medical rubber product |
| 04/20/2005 | CN1197621C Medicinal compositions promoting bowel movement |
| 04/20/2005 | CN1197598C Biological wall breaking technology for rape melissa powder |
| 04/20/2005 | CN1197577C Therapeutic use of 4-anilino quinazoline derivative in preparing drug for preventing breast cancer paroxysm |
| 04/20/2005 | CN1197565C Method for preventing or delaying catheter-based revascularization |
| 04/20/2005 | CN1197551C Dispersion formulations containing lipase inhibitors |
| 04/20/2005 | CN1197541C Two chamber cartridge for atomizers |
| 04/20/2005 | CN1197481C Method for treatment of chronic venous functionalinsufficiencies using extract of red vine leaves |
| 04/19/2005 | US6881841 Dibenzosuberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 04/19/2005 | US6881823 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing |
| 04/19/2005 | US6881756 Method for treating skin disorders |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881749 Pyranoindazoles and their use for the treatment of glaucoma |
| 04/19/2005 | US6881745 Pharmaceutical compositions for poorly soluble drugs |
| 04/19/2005 | US6881743 Pyridine matrix metalloproteinase inhibitors |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |